Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach-perspectives from the International Progressive MS Alliance.
Paola ZaratinBrenda BanwellTimothy CoetzeeGiancarlo ComiAnthony FeinsteinRobert HydeMarco SalvettiKathryn SmithPublished in: Multiple sclerosis journal - experimental, translational and clinical (2022)
This paper's calls to action could represent a path toward a shared research agenda. Multi-stakeholder and long-term investigations will be required to drive and evolve such an agenda.